A novel anti-tumor inhibitor identified by virtual screen with PLK1 structure and zebrafish assay.
Polo-like kinase 1 (PLK1), one of the key regulators of mitosis, is a target for cancer therapy due to its abnormally high activity in several tumors. Plk1 is highly conserved and shares a nearly identical 3-D structure between zebrafish and humans. The initial 10 mitoses of zebrafish embryonic clea...
Saved in:
| Main Authors: | Jing Lu, Shengchang Xin, Huan Meng, Matt Veldman, David Schoenfeld, Chao Che, Ruibin Yan, Hanbing Zhong, Song Li, Shuo Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053317&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1
by: Yang Xia, et al.
Published: (2025-12-01) -
Disruption of LRRK2 does not cause specific loss of dopaminergic neurons in zebrafish.
by: Guiqi Ren, et al.
Published: (2011-01-01) -
Discovery of a novel PLK1 inhibitor with high inhibitory potency using a combined virtual screening strategy
by: Zhen Xu, et al.
Published: (2025-12-01) -
Discovery of novel dual-targeting inhibitors against PLK1-PBD and PLK4-PB3: structure-guided pharmacophore modelling, virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation
by: Changhao Zhao, et al.
Published: (2025-12-01) -
Identifying Natural Products as Feline Coronavirus Mpro Inhibitors by Structural-Based Virtual Screening and Enzyme-Based Assays
by: Zunyun Jiang, et al.
Published: (2025-01-01)